ZyVersa Therapeutics Appoints Three New Board Members
New appointments bring expertise and proven leadership to ZyVersa to support advancement and development of VAR 200 for renal disease, and IC 100 ...
Source: businessinsider.com
Variant Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Variant Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Variant Pharmaceuticals Today - Breaking & Trending Today
ZyVersa Therapeutics Adds Two Esteemed Leaders in Nephrology to Its Renal Scientific Advisory Board to Support Clinical Advancement of Lead Renal Drug Candidate, VAR 200
Drs. Daniel C. Cattran and Fernando C. Fervenza join ZyVersa's distinguished group of Scientific AdvisorsVAR 200 is a phase 2a-ready cholesterol e...
Source: businessinsider.com
ZyVersa Therapeutics' CEO, Stephen C. Glover, Is Invited Speaker at BioFlorida 2022 Annual Conference
Mr. Glover will be joining four other life science executives in a General Session titled, CEO Panel: Learn from the expertsZyVersa is a clinical ...
Source: businessinsider.com